Pharmather Holdings Ltd C.PHRM

PharmaTher Reports Financial Results

[Betteryear2]

Nearly $12 million in cash and investment

Fully funded for the Company’s development programs, including ketamine injection and infusion product, ketamine microneedle patch and ketamine wearable pump device for mental health, neurological, and pain disorders

Seeking FDA approval for KETARX™ (ketamine injection and infusion product) for anesthesia and procedural sedation

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today reported financial results for its third quarter ended February 28, 2022, and provided recent business highlights and update. All amounts are stated in Canadian dollars unless otherwise indicated. 

PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update

 

[Iamjaygee]

Nice, cashed up, and everything still moving forward. No downward pressure anymore.. They have almost as much free cash as their mkt cap.. lol We're in a good position, wish I would have averaged down more at 10.